InVitria was founded to improve cell culture, bio-manufacturing, and final product formulation.
InVitria is a leading developer and manufacturer of recombinant proteins and supplements used by leaders in biomanufacturing and final formulation of vaccines, biologic medicines, cell therapies, gene therapies and regenerative medicines. Our products are sustainable by design, utilizing our ExpressTec system that employs plants as the production host and eliminates animal-derived components from gene to final product.